Perspectives on Outsourcing

Jul 01, 2018
BioPharm International
This article highlights 15 years of changes in biopharmaceutical manufacturing.
Jun 01, 2018
BioPharm International
By BioPharm International Editors
New and expanded facilities point to the continuing growth of the biopharmaceutical industry.
May 01, 2018
BioPharm International
CDMOs can claim credit for the robust growth of emerging bio/pharma financings.
Mar 01, 2018
BioPharm International
Development and adoption of new technologies create challenges that may take years to resolve.
Jan 01, 2018
BioPharm International
The industry will see an impact from financing, M&As, advanced therapies, generic drugs, and the retail market in 2018.
Dec 01, 2017
BioPharm International
In a productive year, 2017 was filled with acquisitions, facility expansions, and new biopharma technology.
Nov 01, 2017
BioPharm International
Recent acquisitions are creating CDMOs with scale that rivals global bio/pharma.
Oct 01, 2017
BioPharm International
Mergers and acquisitions are positive for the CDMO industry, but there is a downside.
Sep 01, 2017
BioPharm International
Innovation speeds discovery, drives down costs, and improves productivity.
Aug 01, 2017
BioPharm International
Despite some progress, the industry is still in a wait-and-see mode regarding the administration, Congress, and FDA.
lorem ipsum